Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
36.5% below 52-week high
37.88
37.5452W Low
59.6852W High
1 Week
12.5% below 1-week high
37.541W Low
43.291W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $37.54 and $59.68 over the past 52 weeks and last traded at $37.88, 36.5% below its 52-week high. Over the past week it ranged between $37.54 and $43.29.
Past 12 Months
-11.5%
-11.7%
-20.1%
-26.1%
-23.4%
-24.5%
1W
-$4.93
1M
-$5.04
3M
-$9.54
6M
-$13.37
YTD
-$11.59
1Y
-$12.29
SUPN was -24.5% over the past year, -26.1% over six months, -23.4% year to date, -11.5% in the last week.
12 Months vs Market
SUPN
DIA
SPY
QQQ
IWM
Over the past 12 months SUPN returned -24.5% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.
Volume & Liquidity
1.83× 3-mo avg
Today 1,441,633
3-mo avg 788.0K
1W
1M
3M
6M
YTD
1Y
SUPN most recently traded 1,441,633 shares against a 3-month average daily volume of 788.0K. More NewsRead More
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
Via StockStory
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
Via StockStory
Topics
Credit Cards
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
Via StockStory
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Via StockStory
1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Headwinds
September 08, 2026
Via StockStory
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
Via GlobeNewswire
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
Via StockStory
3 Small-Cap Stocks with Open Questions
August 25, 2026
Via StockStory
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
Via StockStory
Topics
Retirement
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Via StockStory
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Via The Motley Fool
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics
Earnings
What's going on in today's pre-market session ↗
August 03, 2026
Via Chartmill
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Via GlobeNewswire
Frequently Asked QuestionsIs Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 37.88
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.01B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>